Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System
- Conditions
- Childhood Atypical Teratoid/Rhabdoid Tumor
- Interventions
- Radiation: 3-Dimensional Conformal Radiation TherapyProcedure: Autologous Hematopoietic Stem Cell TransplantationBiological: FilgrastimOther: Laboratory Biomarker Analysis
- First Posted Date
- 2008-04-04
- Last Posted Date
- 2024-04-23
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 70
- Registration Number
- NCT00653068
- Locations
- πΊπΈ
Children's Hospital of Alabama, Birmingham, Alabama, United States
πΊπΈUniversity of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
πΊπΈUniversity of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors
- Conditions
- Ewing Sarcoma of BoneLocalized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
- Interventions
- Other: radiation therapyOther: therapeutic conventional surgeryBiological: filgrastim
- First Posted Date
- 2008-02-20
- Last Posted Date
- 2014-09-25
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 35
- Registration Number
- NCT00618813
- Locations
- πΊπΈ
Children's Oncology Group, Monrovia, California, United States
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
- Conditions
- Localized Resectable NeuroblastomaLocalized Unresectable NeuroblastomaRecurrent NeuroblastomaRegional NeuroblastomaStage 4 NeuroblastomaStage 4S Neuroblastoma
- Interventions
- Procedure: Autologous Hematopoietic Stem Cell TransplantationRadiation: External Beam Radiation TherapyBiological: FilgrastimOther: Laboratory Biomarker AnalysisProcedure: Peripheral Blood Stem Cell TransplantationOther: Pharmacological Study
- First Posted Date
- 2007-12-05
- Last Posted Date
- 2022-04-28
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 665
- Registration Number
- NCT00567567
- Locations
- πΊπΈ
Children's Hospital of Alabama, Birmingham, Alabama, United States
πΊπΈUniversity of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
πΊπΈUSA Health Strada Patient Care Center, Mobile, Alabama, United States
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Conditions
- Acute Undifferentiated LeukemiaAcute Lymphoblastic LeukemiaChildhood T Acute Lymphoblastic Leukemia
- Interventions
- Procedure: Biospecimen CollectionProcedure: Bone Marrow BiopsyProcedure: EchocardiographyBiological: FilgrastimOther: Laboratory Biomarker AnalysisProcedure: Multigated Acquisition ScanOther: Pharmacological Study
- First Posted Date
- 2007-11-12
- Last Posted Date
- 2024-07-15
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 218
- Registration Number
- NCT00557193
- Locations
- πΊπΈ
Children's Hospital of Alabama, Birmingham, Alabama, United States
πΊπΈUniversity of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
πΊπΈPhoenix Childrens Hospital, Phoenix, Arizona, United States
Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma
- Conditions
- Extraocular Retinoblastoma
- Interventions
- Procedure: Autologous Bone Marrow TransplantationProcedure: Autologous Hematopoietic Stem Cell TransplantationProcedure: In Vitro-Treated Peripheral Blood Stem Cell TransplantationRadiation: Radiation Therapy
- First Posted Date
- 2007-11-07
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 60
- Registration Number
- NCT00554788
- Locations
- πΊπΈ
Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia, United States
πΊπΈChildren's Hospital of Alabama, Birmingham, Alabama, United States
πΊπΈUniversity of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia
- Conditions
- Leukemia
- Interventions
- Biological: anti-thymocyte globulinOther: laboratory biomarker analysisOther: pharmacological studyProcedure: allogeneic bone marrow transplantationProcedure: allogeneic hematopoietic stem cell transplantation
- First Posted Date
- 2007-11-04
- Last Posted Date
- 2020-04-16
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 158
- Registration Number
- NCT00553202
- Locations
- πΊπΈ
UAB Comprehensive Cancer Center, Birmingham, Alabama, United States
πΊπΈPhoenix Children's Hospital, Phoenix, Arizona, United States
πΊπΈJonathan Jaques Children's Cancer Center at Miller Children's Hospital, Long Beach, California, United States
Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia
- Conditions
- Adult Acute Lymphoblastic LeukemiaChildhood Acute Lymphoblastic Leukemia
- Interventions
- First Posted Date
- 2007-09-28
- Last Posted Date
- 2019-07-09
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 59
- Registration Number
- NCT00537030
- Locations
- πΊπΈ
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
πΊπΈPhoenix Childrens Hospital, Phoenix, Arizona, United States
πΊπΈKaiser Permanente Downey Medical Center, Downey, California, United States
Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
- Conditions
- Neuroblastoma
- Interventions
- First Posted Date
- 2007-07-11
- Last Posted Date
- 2021-07-06
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 464
- Registration Number
- NCT00499616
- Locations
- πΊπΈ
UAB Comprehensive Cancer Center, Birmingham, Alabama, United States
πΊπΈUniversity of South Alabama Mitchell Cancer Institute, Mobile, Alabama, United States
πΊπΈPhoenix Children's Hospital, Phoenix, Arizona, United States
Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Conditions
- Untreated Childhood Acute Lymphoblastic LeukemiaUntreated Adult Acute Lymphoblastic Leukemia
- Interventions
- Other: laboratory biomarker analysis
- First Posted Date
- 2007-06-05
- Last Posted Date
- 2023-08-03
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 11196
- Registration Number
- NCT00482352
- Locations
- πΊπΈ
University of Alabama at Birmingham, Birmingham, Alabama, United States
πΊπΈUniversity of South Alabama, Mobile, Alabama, United States
πΊπΈPhoenix Childrens Hospital, Phoenix, Arizona, United States
Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia
- First Posted Date
- 2007-05-07
- Last Posted Date
- 2017-03-15
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 14
- Registration Number
- NCT00469859
- Locations
- πΊπΈ
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham, Birmingham, Alabama, United States
πΊπΈChildren's Hospital of Orange County, Orange, California, United States
πΊπΈChildren's National Medical Center, Washington, District of Columbia, United States